• First-line Keytruda Doubles 5-Year Survival in Certain Lung Cancer Patients, Data Show
  • Tecentriq-Avastin Combo Recommended for EU Approval for Liver Cancer
  • EU Approval Recommended for Opdivo-Yervoy-Chemo Combo for Advanced NSCLC
  • FDA Acts to Speed Toripalimab as Potential Nasopharyngeal Cancer Treatment
  • EMA to Review Opdivo-Yervoy Combo for Untreated, Inoperable Mesothelioma
  • Post-surgery Opdivo Shows Benefits for Esophageal, GEJ Cancer Patients in Ongoing Trial
  • Strong Response for Tessa’s CD30 CAR-T Cell Therapy in Hodgkin’s Lymphoma Trial
  • FDA Rejects Keytruda-Lenvima Combo as First-line Treatment for Liver Cancer
  • Imfinzi Approved in EU for Extensive-stage Small Cell Lung Cancer
  • Imfinzi as Once Monthly NSCLC, Bladder Cancer Treatment Under FDA Review
  • Novocure, MSD Team Up to Test TTFields-Keytruda Combo in Lung Cancer
  • Health Canada Approves Opdivo-Yervoy-Chemo Combo for Advanced NSCLC